Prescription drug pricing has been an ongoing issue in the US, which is reportedly spending more than double the average amount spent by other OECD member countries on prescription medicines per capita.
Florida’s Canadian Prescription Drug Importation Program, which will initially focus on a small number of drug classes to treat conditions such as HIV/AIDS, diabetes and prostate cancer, is expected to save the state up to $180m in its first year.
